In the last trading session, 1,233,253 shares of the GeoVax Labs, Inc. (NASDAQ:GOVX) were traded, and its beta was 1.65. Most recently the company’s share price was $4.32, and it changed around -$0.02 or 0% from the last close, which brings the market valuation of the company to $27.28 Million. GOVX currently trades at a discount to its 52-week high of $8.71, offering almost -101.62% off that amount. The share price’s 52-week low was $2.56, which indicates that the current value has risen by an impressive 40.74% since then. We note from GeoVax Labs, Inc.’s average daily trading volume that its 10-day average is 328.43 Million shares, with the 3-month average coming to 1.84 Million.
GeoVax Labs, Inc. stock received a consensus recommendation rating of Buy, based on a mean score of 0. If we narrow it down even further, the data shows that none out of 1 analysts rate the stock as a Sell; another but none rate it as Overweight. Among the rest, no body recommended GOVX as a Hold, whereas 1 deemed it a Buy, and no one rated it as Underweight. GeoVax Labs, Inc. is expected to report earnings per share of $0 for the current quarter.
GeoVax Labs, Inc. (NASDAQ:GOVX): Trading Information
Although GOVX has showed a red trend with a performance of -0.46% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of $4.95- on Thursday, Apr 01 increased the stock’s daily price by 12.73%. The company’s shares are currently up 0.28% year-to-date, but still up 0.031 over the last five days. On the other hand, GeoVax Labs, Inc. (NASDAQ:GOVX) is -0.01% down in the 30-day period. We can see from the shorts that 398.01 Million shares have been sold at a short interest cover period of 216.31 day (s).
The consensus price target as assigned by Wall Street analysts is $8, which translates to bears needing to increase their stock price by 85.19% from its current value. Analyst projections state that GOVX is forecast to be at a low of $8 and a high of $8. In order for the stock price to hit the forecast high, the stock would need to surge +85.19% from its current level, while the stock would need to crash 85.19% from its current level to reach the projected low.
GeoVax Labs, Inc. (GOVX) projections and forecasts
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of 0%. GeoVax Labs, Inc. earnings are expected to increase by 99.7% in 2021, but the outlook is negative 0% per year for the next five years.
GeoVax Labs, Inc. (NASDAQ:GOVX)’s Biggest Investors
Upon looking at major shareholders, it appears that insiders hold 8.32% of GeoVax Labs, Inc. shares, and 4.53% of them are in the hands of institutional investors. The stock currently has a share float of 4.94%. GeoVax Labs, Inc. stock is held by 13 institutions, with Sabby Management, LLC being the largest institutional investor. By Dec 30, 2020, it held 0.89% of the shares, which is about 56.38 Thousand shares worth $190.56 Thousand.
Welch & Forbes, LLC, with 0.44% or 27.99 Thousand shares worth $94.62 Thousand as of Dec 30, 2020, holds the second largest percentage of outstanding shares.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Feb 27, 2021. The former held 29217 shares worth $149.01 Thousand, making up 0.46% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 22.24 Thousand shares worth around $75.17 Thousand, which represents about 0.35% of the total shares outstanding.